The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease
Open accessAbstract
Objective: Auto-antibodies directed to dsDNA (anti-dsDNA) are used in diagnosis and follow-up for SLE. However, multiple assays are used. The objective of this study was to determine the best-performing assays, especially in prediction of exacerbations. Methods: Seven assays were compared during LN (n = 58). The two assays with the most frequent positive results during active nephritis were selected and tested in 152 SLE patients with quiescent disease, 40 with active disease and 214 disease controls. Furthermore, longitudinal samples of SLE patients with and without exacerbations were examined to determine the positive predictive value of an increase for an exacerbation. Results: Of seven assays, results of the Farr (Siemens) and enzyme-labelled anti-isotype assay (EliA) (ThermoFisherScientific) were foremost associated with active nephritis (both 95%). Sensitivity in active SLE was equal using Farr or EliA (95 vs 93%). In quiescent disease, the specificity of EliA was higher (Farr: 53% vs EliA: 91%). In longitudinal analyses, a 25% increase of anti-dsDNA preceded an exacerbation in 75 vs 69% (Farr vs EliA). In SLE patients without exacerbations (n = 42), a rise was seen in 10 vs 12%. Increases in anti-dsDNA occurred more often prior to nephritis (n = 17) compared with non-nephritic flares (n = 17), which was not different between both assays (Farr: 82 and 66%, respectively; EliA: 93 and 43%, respectively). Conclusion: Anti-dsDNA is most frequently positive using Farr and EliA during active nephritis, with comparable sensitivity. Both assays performed equally during exacerbations. However, EliA had higher specificity in quiescent disease and had several advantages, including no use of radioactive materials and less time required.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Bertsias, G., Ioannidis, J. P. A., Boletis, J., Bombardieri, S., Cervera, R., Dostal, C., Font, J., Gilboe, I. M., Houssiau, F., Huizinga, T., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.070367 · Cited by 762
Prevention of relapses in systemic lupus erythematosus
Bootsma, H., Spronk, P., de Boer, G., Limburg, P., Kallenberg, C., Derksen, R., Wolters-Dicke, J., Gmelig-Meyling, F., Kater, L., & Hermans, J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90114-0 · Cited by 290
Self-citationFifty years of anti-ds DNA antibodies: are we approaching journey's end?
Isenberg, D. A., Manson, J. J., Ehrenstein, M. R., & Rahman, A. (2007) · Rheumatology · doi:10.1093/rheumatology/kem112 · Cited by 281
Grootscholten, C., Erythematosus, F. T. D. W. P. O. S. L., Ligtenberg, G., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5001630 · Cited by 237
Bootsma, H., Spronk, P. E., Borg, E. J. T., Hummel, E. J., de Boer, G., Limburg, P. C., & Kallenberg, C. G. M. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.11.661 · Cited by 115
Self-citationAnti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?
Riboldi, P., Gerosa, M., Moroni, G. L., Radice, A., Allegri, F., Sinico, A., Tincani, A., & Meroni, P. L. (2005) · Autoimmunity · doi:10.1080/08916930400022616 · Cited by 104
Beigel, F., Schnitzler, F., Paul Laubender, R., Pfennig, S., Weidinger, M., Göke, B., Seiderer, J., Ochsenkühn, T., & Brand, S. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21362 · Cited by 84
Enocsson, H., Sjöwall, C., Wirestam, L., Dahle, C., Kastbom, A., Rönnelid, J., Wetterö, J., & Skogh, T. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.140677 · Cited by 73
Clinical evaluation of a new automated anti-dsDNA fluorescent immunoassay
Hernando, M., González, C., Sánchez, A., Guevara, P., Navajo, J. A., Papisch, W., & González-Buitrago, J. M. (2002) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2002.185 · Cited by 35
Derksen, R. H. W. M., Bast, E. J. E. G., Strooisma, T., & Jacobs, J. W. G. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.12.1099 · Cited by 33
Fiegel, F., Buhl, A., Jaekel, H.-P., Werle, E., Schmolke, M., Ollert, M., & Luppa, P. (2010) · Lupus · doi:10.1177/0961203310369681 · Cited by 24
Hillebrand, J., Moens, H. B., & Mulder, A. (2013) · Lupus · doi:10.1177/0961203313500368 · Cited by 21
Arends, S., Berden, J. H. M., Grootscholten, C., et al. (2014) · PubMed · Cited by 14
Flagged first, then by citations
Cited by
Sorted by citations
Becker, Y., Loignon, R.-C., Julien, A.-S., Marcoux, G., Allaeys, I., Lévesque, T., Rollet-Labelle, E., Benk-Fortin, H., Cloutier, N., Melki, I., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40900-3 · Cited by 75
Orme, M. E., Voreck, A., Aksouh, R., Ramsey-Goldman, R., & Schreurs, M. W. J. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102943 · Cited by 34
Becker, Y. L. C., Gagné, J., Julien, A., Lévesque, T., Allaeys, I., Gougeard, N., Rubio, V., Boisvert, F., Jean, D., Wagner, E., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42082 · Cited by 26
de Leeuw, K., Bungener, L., Roozendaal, C., Bootsma, H., & Stegeman, C. A. (2017) · Rheumatology · doi:10.1093/rheumatology/kex314 · Cited by 19
Self-citationInfantino, M., Manfredi, M., Merone, M., Grossi, V., Benucci, M., Li Gobbi, F., Bandinelli, F., Damiani, A., & Soda, P. (2018) · Immunologic Research · doi:10.1007/s12026-018-8992-9 · Cited by 16
Lakota, K., Švec, T., Kveder, T., Sodin-Šemrl, S., Žigon, P., Ambrožič, A., Ogrič, M., Markez, S., Božič, B., Tomšič, M., et al. (2019) · Clinical Rheumatology · doi:10.1007/s10067-018-4271-3 · Cited by 10
Metadata
- Authors
- de Leeuw, K., Bungener, L., Roozendaal, C., Bootsma, H., & Stegeman, C. A.
- Affiliations
- University Medical Center Groningen (NL)
- Venue
- Rheumatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-01-03
- Volume
- 56
- Issue
- 5
- Pages
- kew462
- ISSN
- 1462-0324 (ISSN-L)
- 1462-0332
- OpenAlex
- W2571267366
- Cited by
- 24
- References
- 14
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 4 · 2021: 6 · 2020: 2 · 2019: 1 · 2018: 5 · 2017: 2
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- green
- research.rug.nl
- Licence
- other-oa
- Locations
- Lara D. Veeken (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- anti-dsDNA antibodies, systemic lupus erythematosus, lupus nephritis, Farr assay, assay comparison, sensitivity and specificity, quiescent disease
- MeSH terms
- Adult, Antibodies, Antinuclear, Autoantibodies, DNA, Female, Humans, Immunoenzyme Techniques, Lupus Erythematosus, Systemic, Male, Middle Aged, Sensitivity and Specificity, Biomarkers, Case-Control Studies, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
